Income Statement (TTM)
Dicot Pharma AB Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
|
|---|---|
| Revenue | 1 |
| Change (%) | |
| % of Revenue | 100.00 |
| Cost Of Sales | |
| Change (%) | |
| % of Revenue | |
| Gross Operating Profit | 1 |
| Change (%) | |
| % of Revenue | 100.00 |
| SG&A | 26 |
| Change (%) | |
| % of Revenue | 4,673.27 |
| R&D | |
| Change (%) | |
| % of Revenue | |
| OpEx | 17 |
| Change (%) | |
| % of Revenue | 3,172.37 |
| Operating Income | -17 |
| Change (%) | |
| % of Revenue | -3,072.37 |
| Interest Expense | -0 |
| Change (%) | |
| % of Revenue | -2.73 |
| Net Income | -17 |
| Change (%) | |
| % of Revenue | -3,073.85 |
Source: Capital IQ
